

HY-146245C · 1 mg
MedChemExpress · Cat: HY-146245C
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/odn-1826-sodium.html
Description
ODN 1826 sodium is a class B CpG ODN oligodeoxynucleotide and TLR9 agonist. ODN 1826 sodium induces NO and iNOS production and enhances Apoptosis. ODN 1826 sodium enhances immune surveillance. ODN 1826 sodium increases aortic atherosclerotic plaque size. ODN 1826 sodium has antitumor activity against lung cancer, glioma and melanoma.







